CD19 and acute myeloid leukemia: For example, although efforts by Perna et al. to identify singular CAR targets for acute myeloid leukemia (AML) were unable to reveal candidates with a profile as favorable as CD19, a generalizable approach and discovery platform for combinatorial antigen targeting was described18.